AD-227 / Yuhan Corp - LARVOL DELTA

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B (clinicaltrials.gov) - P1 | N=70 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed | Trial completion date: Apr 2025 ➔ Aug 2025 | Initiation date: Feb 2025 ➔ Jul 2025 | Trial primary completion date: Apr 2025 ➔ Aug 2025

Trial completion • Trial completion date • Trial initiation date • Trial primary completion date • Cardiovascular • Hypertension

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: Addpharma Inc.

New P1 trial • Cardiovascular • Hypertension